Skip to content Skip to footer
Subscribe Now
NEWS

OMass Therapeutics Collaborates with Genentech to Develop and Commercialize Small Molecule for Inflammatory Bowel Disease

OMass has entered into an exclusive collaboration & license deal with Genentech to develop & commercialize its preclinical oral small molecule program for inflammatory bowel disease As per the deal, OMass will receive $20M upfront & over $400M in preclinical, development, commercial, & sales milestones, with tiered royalties based on net sales Collaboration leverages OMass’…
September 2, 2025

Read more

VIEWPOINTS_Dr. Lotus Mallbris_2023
VIEWPOINTS

Dr. Lotus Mallbris Discusses Positive Results from the VIVID-1 P-III Study of Mirikizumab for the Treatment of Crohn’s Disease in Adults

Shots:    Dr. Lotus Mallbris shares the positive endpoint results of the VIVID-1 P-III study, evaluating the safety and efficacy of mirikizumab for the treatment of adults with moderately to severely active Crohn’s disease    While shedding light on the mechanism of mirkizumab, Lotus highlights that available therapies to treat Crohn’s disease often fail to achieve clinical…
December 19, 2023

Read more

Thoughtspot_Adam_Ferraresi_2023
THOUGHTSPOT

Easing the Storm: Tackling Ulcerative Colitis Flare-ups Effectively

Did you know that 1 in 250 people globally grapple with ulcerative colitis? You're not alone in this fight. This article provides you with practical strategies to manage flare-ups effectively. You'll identify your triggers, explore nutritional strategies, understand medication options, and learn about stress's role. We'll also delve into the benefits of regular exercise and…
November 10, 2023

Read more

Viewpoints_Atray Dixit
VIEWPOINTS

PharmaShots Interview: Coral Genomics’s Atray Dixit Shares Insights on the 2021 Innovation Challenge in Inflammatory Bowel Disease

In an interview with PharmaShots, Atray Dixit, Co-founder & CEO at Coral Genomics share his views on the winner of the $25K inflammatory bowel disease innovation challenge under the collaboration with Lyfebulb and Arena Shots: Lyfebulb and Arena collaborated to discover 2021 Imagining Life Without Limits Challenge to get the solutions for patients with IBD Coral Genomics was selected as…
December 7, 2021

Read more